What is the equivalent dose of lorazepam (Lorazepam) intravenous (IV) for a patient requiring diazepam (Diazepam) 5mg IV?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diazepam to Lorazepam IV Conversion

Diazepam 5mg IV is equivalent to lorazepam 1mg IV. 1, 2

Pharmacological Equivalence Rationale

The conversion between diazepam and lorazepam follows a 5:1 ratio based on multiple sources:

  • The American Academy of Pediatrics indicates that diazepam 10mg IV is equivalent to lorazepam 2mg IV 1
  • Research directly comparing the two medications confirms that diazepam 10mg is equivalent to lorazepam 2-2.5mg 2
  • In clinical practice, this 5:1 ratio is consistently applied when converting between these benzodiazepines

Clinical Pharmacology Comparison

Parameter Diazepam Lorazepam
Onset of action 2-5 minutes 1-5 minutes
Duration of action 20-30 minutes 60-120 minutes
Elimination half-life 20-120 hours 8-15 hours
Loading dose 0.01-0.05 mg/kg 0.02-0.04 mg/kg (≤2 mg)

3, 1

Important Clinical Considerations

Potency and Duration Differences

  • While diazepam has a faster onset, lorazepam has a significantly longer duration of clinical effect 2
  • Lorazepam produces more reliable and prolonged amnesia compared to diazepam 4
  • Lorazepam has less venous irritation when administered IV compared to diazepam 2, 4

Administration Considerations

  • Lorazepam IV should not be administered faster than 2mg per minute to minimize adverse effects 1
  • For status epilepticus, lorazepam 4mg IV has shown better efficacy (80% response) compared to diazepam 5mg IV (57% response) 5

Special Populations

  • Elderly patients (>60 years) require dose reductions of at least 20% for both medications due to increased sensitivity 1
  • Patients with renal impairment may experience prolonged effects from lorazepam glucuronide (the metabolite), though the parent drug clearance is less affected 5
  • Hepatic disease has minimal impact on lorazepam clearance since it doesn't rely on cytochrome oxidation for metabolism 5

Common Pitfalls

  1. Underdosing: Administering less than the equivalent dose may lead to treatment failure, particularly in status epilepticus where underdosing lorazepam is associated with progression to refractory status epilepticus 6

  2. Failure to account for duration differences: While the initial potency conversion is 5:1, clinicians must remember that lorazepam's clinical effects last significantly longer (60-120 minutes vs. 20-30 minutes for diazepam) 1, 7

  3. Inappropriate administration rate: Administering lorazepam too rapidly increases the risk of respiratory depression and hypotension 1

  4. Overlooking context-specific dosing: The 5:1 ratio applies to most clinical scenarios, but specific conditions like status epilepticus may have different optimal dosing protocols 5

References

Guideline

Sedation Guidelines for Benzodiazepines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Comparison of the actions of diazepam and lorazepam.

British journal of anaesthesia, 1979

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical pharmacology of lorazepam.

Contemporary anesthesia practice, 1983

Research

Diazepam and lorazepam for intravenous surgical premedication.

Journal of clinical pharmacology, 1978

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.